Schlagwort: stem cell
DKMS Stem Cell Bank: schnellere Hilfe und eine bessere Chance auf Heilung für Blutkrebspatient:innen
7. Juni 2024
Als weltweit erste Einrichtung stellt die DKMS Stem Cell Bank kryokonservierte periphere Blutstammzellen für allogene Transplantationen zur Verfügung.
First model of the brain’s information highways developed
8. Mai 2024
Our human brain is not only bigger and contains more neurons than the brains of other species, but it is also connected in a special pattern: Thick bundles of neurons connect brain regions across long distances, such as the right and left brain hemispheres. A team of researchers at IMBA, including Catarina Martins-Costa, Nina Corsini and Jürgen Knoblich, now presents the first organoid model in which these information highways can be studied. Their results are published on May 7th in the journal Cell Stem Cell.
Model der Autobahnen im Gehirn entwickelt
8. Mai 2024
Unser menschliches Gehirn ist nicht nur größer und enthält mehr Nervenzellen als die Gehirne anderer Arten, sondern ist auf eine ganz besondere Weise vernetzt: Dicke Nervenbündel verbinden Gehirnregionen über weite Strecken, etwa die linke und die rechte Gehirnhälfte. Ein ForscherInnenteam des IMBA, rund um Catarina Martins-Costa, Nina Corsini und Jürgen Knoblich, präsentierte nun das erste Organoidmodell, in dem diese Informations-Autobahnen untersucht werden können. Die Ergebnisse erscheinen am 7. Mai im Fachmagazin Cell Stem Cell.
Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024
17. April 2024
DKMS emphasizes its commitment to blood cancer research, supports young scientists, and recognizes outstanding research achievements in the field of stem cell transplantation.
Ways to achieve a peaceful co-existence with genomic parasites
15. Februar 2024
Transposable elements are mobile genetic elements that can relocate within the genome and disrupt the normal function of genes, but are at the same time a source of evolutionary diversity. The lab of Tugce Aktas at the Max Planck Institute for Molecular Genetics has identified a novel pathway that keeps the activity of transposons in somatic cells in check after they have been transcribed. Their findings have now been published in Nature. The work is a collaboration with the labs of Zachary D. Smith (Yale Stem Cell Center, USA) and Franz-Josef Müller (Universitätsklinikum Schleswig-Holstein, Germany)
Wege zur friedlichen Koexistenz mit genomischen Parasiten
15. Februar 2024
Transposons sind mobile genetische Elemente, die sich innerhalb des Genoms bewegen und die normale Funktion von Genen stören können, gleichzeitig aber auch eine Quelle evolutionärer Vielfalt sind. Das Labor von Tugce Aktas am Max-Planck-Institut für molekulare Genetik hat einen neuen Mechanismus identifiziert, der die Aktivität von Transposons in somatischen Zellen nach ihrer Transkription kontrolliert. Ihre Ergebnisse wurden jetzt in der Fachzeitschrift Nature veröffentlicht. Die Arbeit entstand in Zusammenarbeit mit den Labors von Zachary D. Smith (Yale Stem Cell Center, USA) und Franz-Josef Müller (Universitätsklinikum Schleswig-Holstein, Deutschland).
Aktueller Themenband zu Gen- und Zelltherapien der AG Gentechnologiebericht
2. Februar 2024
Die Arbeitsgruppe Gentechnologiebericht am Berlin Institute of Health in der Charité (BIH) hat eine aktuelle Übersicht zu Gen- und Zelltherapien herausgegeben. Die umfangreiche Publikation, die in Kooperation mit der Deutschen Gesellschaft für Gentherapie (DG-GT) und dem German Stem Cell Network (GSCN) entstanden ist, richtet sich an ein breites Publikum. Der Bedarf an sachkundigen Informationen über Entwicklungen der Gentechnologie ist groß. Hierbei sind Transparenz und ein verantwortungsvoller Umgang mit neuen Technologien unbedingt erforderlich.
The gut microbiome prevents dangerous immune reactions
8. Januar 2024
After stem cell transplantation, the donated immune cells sometimes attack the patients‘ bodies. This is known as graft versus host disease or GvHD. Researchers at the Technical University of Munich (TUM) and the Universitätsklinikum Regensburg (UKR) have shown that GvHD is much less common when certain microbes are present in the gut. In the future, it may be possible to deliberately bring about this protective composition of the microbiome.
Research Grants Endowed with €240,000
8. August 2023
The application period for the DKMS John Hansen Research Grant 2024 began on August 1, 2023. With this grant, the foundation DKMS Stiftung Leben Spenden supports up to four outstanding research projects in the field of stem cell transplantation or cell therapy each year. A stem cell transplant saves the lives of many blood cancer patients. However, relapses and severe complications continue to pose major challenges. The grant is intended to promote excellent science in this field. The application deadline is November 30, 2023.
Successful cure of HIV infection after stem cell transplantation
21. Februar 2023
Haematopoietic stem cell transplantation for the treatment of severe blood cancers is the only medical intervention that has cured two people living with HIV in the past. An international group of physicians and researchers from Germany, the Netherlands, France, Spain, and the United States has now identified another case in which HIV infection has been shown to be cured in the same way. In a study published this week in Nature Medicine, in which DZIF scientists from Hamburg and Cologne played a leading role, the successful healing process of this third patient was for the first time characterised in great detail virologically and immunologically over a time span of ten years.
Acute Myeloid Leukemia: Germany-wide clinical trial challenges international standard of care
12. Dezember 2022
Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML), complete remission is currently still considered the gold standard of care. A Germany-wide clinical trial now shows for the first time that this approach does not benefit disease-free survival or overall survival. An alternative approach of sequential conditioning followed by immediate stem cell transplantation may reduce side effects and shorten hospital stays.
BioRescue produces primordial germ cells from northern white rhino stem cells – a world’s first for large mammals
10. Dezember 2022
In its race to advance assisted reproduction and stem cell associated technologies to save the northern white rhinoceros from extinction, the BioRescue consortium announces a major breakthrough: the creation of primordial germ cell-like cells (PGCLSs) from induced pluripotent stem cells of the northern white rhino Nabire. This milestone was led by specialists from Osaka University, Japan, and has never been achieved in large mammals before. Now there is one last step to master for the production of artificial rhino gametes (eggs and sperm) from preserved tissue.
More than microscopes can show
22. September 2022
Computer simulations visualize how an essential stem cell protein opens wrapped DNA
A key protein for converting adult stem cells into cells that resemble embryonic stem cells has been visualized in unprecedented detail by an international team of researchers around Hans Schöler and Vlad Cojocaru of the Max Planck Institute for Molecular Biomedicine in Münster. By combing experiments and computer simulations, the team visualized how the Oct4 protein binds and opens short pieces of DNA while wrapped around nuclear storage proteins (histones), just like in our genome. The results were published in the journal Nucleic Acids Research on September 22.
Research grants endowed with €240,000 each
11. August 2022
Scientists with a research focus on stem cell transplantation and cell therapy are invited to apply for the 2023 DKMS John Hansen Research Grant starting August 10, 2022. With this grant, the DKMS Stiftung Leben Spenden (Foundation for Giving Life) supports up to four outstanding research projects each year that aim to advance the medical progress and improve the chances of recovery for blood cancer patients. The requirements include a doctoral degree (PhD, MD or equivalent) that was obtained no longer than 10 years ago. The grants are endowed with €240,000 each, which will be paid out over a period of three years. The application deadline is December 2, 2022.
New Stem Cell Mechanism in Your Gut
14. Juli 2022
Stem cells are a hot topic for creating medical treatments. However, scientists still do not fully understand how they choose to divide or differentiate to renew organs. Researchers have now found a new biophysical mechanism that regulates stem cells in the intestines of mice. There, a stem cell is not purely defined by intrinsic molecular markers but also by their location and movements in their environment. This could have implications for possible new treatments.
EBiSC2 and FAIRplus are improving FAIRness of stem cell data
17. Mai 2022
The FAIRplus and EBiSC2 projects are joining forces to improve how ‘FAIR’ standards (Findability, Accessibility, Interoperability and Reusability) can be applied to human induced Pluripotent Stem Cell (iPSC) line data. The joint effort will improve how iPSC line data can be made more findable, standardized and reusable for researchers.
Double agents: How stomach stem cells change allegiance upon injury
6. Mai 2022
A stomach adult stem cell population can fulfill two distinct functions: either help with digestion under normal conditions or take the lead on injury response. Scientists at IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, demonstrate that these functions are two sides of a coin. Upon injury, one “molecular switch” is enough to propel the stem cells from one state to the other. The findings, now published in Cell Stem Cell, could be instrumental in improving our understanding of gastric pathologies.
Comprehensive map of human blood stem cell development
14. April 2022
Scientists have created a new roadmap that traces each step in the development of blood stem cells in the human embryo, providing scientists with a blueprint for producing fully functional blood stem cells in the lab. The research could help expand treatment options for blood cancers like leukemia and inherited blood disorders such as sickle cell disease.
Study finds 10-second videos predict blood cancer relapse
30. März 2022
Ten-second videos of white blood cell motion in the skin’s microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would have a relapse of their blood cancer.
Researchers identify key regulator of blood stem cell development
29. Januar 2022
A protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body, according to a new study.
Two New Studies for Better Chances of Recovery after Stem Cell Transplantation
27. Januar 2022
The most dangerous side effect of allogeneic blood stem cell transplantation, graft-versus-host disease (GvHD), has still not been sufficiently researched. The world’s largest blood stem cell donor center DKMS wants to change that – it is the declared goal of the non-profit organization to improve the survival and healing chances of blood cancer patients. In the fight against GvHD, DKMS research teams have now launched two new scientific studies.
Stem cell discoveries hold potential to improve cancer treatment
26. Januar 2022
Recent discoveries by stem cell scientists may help make cancer treatment more efficient and shorten the time it takes for people to recover from radiation and chemotherapy.
New graft strategy may improve outcomes for blood stem cell recipients
11. Januar 2022
Removing one type of T cell from donor blood used for stem cell grafts could greatly reduce a serious complication called graft-versus-host disease in patients with leukemia, according to a new study.
New potential treatment for graft-versus-host-disease and other inflammatory disorders
20. Dezember 2021
Researchers have shown that blocking IL-6 and TNF cytokines provides a more effective approach to preventing life-threatening graft-versus-host-disease, an inflammatory condition that develops in patients after their allogeneic hematopoietic stem cell transplantation.
New technique may lead to safer stem cell transplants
12. November 2021
Studying mice, researchers have developed a method of stem cell transplantation that does not require radiation or chemotherapy. Instead, the strategy takes an immunotherapeutic approach, combining the targeted elimination of blood-forming stem cells in the bone marrow with immune-modulating drugs to prevent the immune system from rejecting the new donor stem cells.